Ro 13-7410, also known as AGN-191183, is primarily utilized in the field of ophthalmology. It is a synthetic retinoid that has been studied for its potential in treating various eye conditions. One of its key applications is in the management of retinal disorders, particularly those involving the degeneration of retinal tissues. The compound has shown promise in slowing the progression of diseases such as retinitis pigmentosa and age-related macular degeneration by promoting the survival of retinal cells and improving visual function. Additionally, Ro 13-7410 has been explored for its role in modulating retinal gene expression, which could be beneficial in developing therapeutic strategies for inherited retinal diseases. Its ability to influence cellular differentiation and apoptosis in retinal cells makes it a valuable candidate for further research in vision preservation and restoration therapies.